“I am disappointed to say that a place that is very dear to me, Woodbine in Canada, has a withdrawal time of seven days, which I find to be totally unacceptable and leads to unimaginable form reversals on a weekly basis. I must say that it is not Woodbine’s fault or the CEO Jim Lawson’s, but more the governmental agencies that have not found it fit to change.” – Mark Casse
Multiple Canadian champion trainer MARK CASSE, who saddled the winners of 2 of the 3 American Triple Crown races in 2019 and is on the short list to be inducted into the National Museum of Racing Hall of Fame at Saratoga this summer, had strong words for the drug Clenbuterol and tracks that allow it, trainers that use it and owners who do not know what is on their vet bill.
In response to Mark’s editorial, Woodbine CEO Jim Lawson said on March 3 on Twitter –
“We are supportive of Mark’s views on the abuse of clenbuterol in the industry and we have been working to address and we are scheduled to meet with our regulators again this week”
Click here to read Mark Casse’s letter.
More from Industry:
